BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31032220)

  • 1. Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin.
    Liu C; Wang L; Jiang Q; Zhang J; Zhu L; Lin L; Jiang H; Lin D; Xiao Y; Fang W; Guo S
    Front Oncol; 2019; 9():211. PubMed ID: 31032220
    [No Abstract]   [Full Text] [Related]  

  • 2. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 3. ZEB1 promotes invasion and metastasis of endometrial cancer by interacting with HDGF and inducing its transcription.
    Xiao YY; Lin L; Li YH; Jiang HP; Zhu LT; Deng YR; Lin D; Chen W; Zeng CY; Wang LJ; Chen SC; Jiang QP; Liu CH; Fang WY; Guo SQ
    Am J Cancer Res; 2019; 9(11):2314-2330. PubMed ID: 31815037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.
    Tang J; Shi H; Li H; Zhen T; Dong Y; Zhang F; Yang Y; Han A
    Tumour Biol; 2016 Aug; 37(8):10287-301. PubMed ID: 26842923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5.
    Liang X; Tang Z; Zhang Y; Sun Y; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1234-1243. PubMed ID: 36148951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis.
    Cheng C; Li W; Peng X; Liu X; Zhang Z; Liu Z; Deng T; Luo R; Fang W; Deng X
    Mol Ther Methods Clin Dev; 2021 Mar; 20():615-624. PubMed ID: 33718512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-939 Directly Targets
    Situ J; Zhang H; Jin Z; Li K; Mao Y; Huang W
    Onco Targets Ther; 2020; 13():4257-4270. PubMed ID: 32547060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.
    Song Y; Hu Z; Long H; Peng Y; Zhang X; Que T; Zheng S; Li Z; Wang G; Yi L; Liu Z; Fang W; Qi S
    J Neurooncol; 2014 Sep; 119(2):285-95. PubMed ID: 24986090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
    Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
    Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer.
    Ma Z; Feng J; Guo Y; Kong R; Ma Y; Sun L; Yang X; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Cheng Y; Zha D; Liu S
    Oncol Res; 2017 Jul; 25(6):887-895. PubMed ID: 28244855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
    Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
    J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Curcumin suppresses invasiveness and migration of human glioma cells in vitro by inhibiting HDGF/β-catenin complex].
    Luo Q; Luo H; Fu H; Huang H; Huang H; Luo K; Li C; Hu R; Zheng C; Lan C; Tang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Aug; 39(8):911-916. PubMed ID: 31511210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway.
    Xue Y; Jia X; Li L; Dong X; Ling J; Yuan J; Li Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2885-2891. PubMed ID: 30119889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer.
    Xiaohua Zhu ; Xie Y; Huang W; Chen Z; Guo S
    BMC Cancer; 2022 Mar; 22(1):339. PubMed ID: 35351053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
    Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
    J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-873 inhibits the proliferation and invasion of endometrial cancer cells by directly targeting hepatoma-derived growth factor.
    Wang Q; Zhu W
    Exp Ther Med; 2019 Aug; 18(2):1291-1298. PubMed ID: 31363373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
    Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z
    PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.
    Zhang C; Chang X; Chen D; Yang F; Li Z; Li D; Yu N; Yan L; Liu H; Xu Z
    Cancer Manag Res; 2019; 11():7909-7923. PubMed ID: 31692549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.